Tian L, Wang M, Liu M, Pang Y, et al. Cardiovascular and renal safety outcomes of hypoxia-inducible factor prolyl-hydroxylase inhibitor roxadustat for anemia patients with chronic kidney disease: a systematic review and meta-analysis. Ren Fail 2024;46:2313864.
PMID: 38345037